Explore
Search
Learn
Watch
Portfolio
TRAX
First Tracks Biotherapeutics, Inc.
Healthcare
$44.04
$44.04
$15.32
52 weeks
$47.80
TRAX
First Tracks Biotherapeutics, Inc.
$44.04
Overview
Safety
Valuation
Market
Financials
Ownership
Who owns it
opening the register…
More on First Tracks Biotherapeutics, Inc.
TRAX overview
Price, RyuScore, the earnings flow and the five questions at a glance.
TRAX revenue and segments
The quarter as a flow, the full statements, and what the business is made of.
TRAX financial charts
Every reported figure as its own chart, quarterly and trailing twelve months.
Is TRAX financially safe?
Distress and accounting checks, debt cover, drawdowns and factor exposure.
Is TRAX overvalued?
What the price assumes, its own history, peer multiples and a fair-value range.
TRAX price history
Trend and momentum, key levels, total return, seasonality.
TRAX SEC filings and events
The company's own record, every flag beside its market-wide base rate.
Biotechnology
The closest names by size in the same industry
Compare peers
Random peer
ABSI
-2.0%
Absci Corporation
NTLA
+0.49%
Intellia Therapeutics, Inc.
MESO
-2.2%
Mesoblast Limited
GENB
-3.1%
Generate Biomedicines, Inc.
QURE
-2.9%
uniQure N.V.
IMCR
-3.4%
Immunocore Holdings plc